ARIMIDEX
1MG TBL FLM 84
SÚKL code | 0231853 |
---|---|
Name of the product | ARIMIDEX |
_MA_MEDICATION_DETAIL_INFO_MED_NAME i | ARIMIDEX |
Supplement | 1MG TBL FLM 84 |
Strenght | 1MG |
Pharmaceutical form | Film-coated tablet |
Package | 84 |
Route | Oral use |
Language of the pack | Czech |
Wrap type | Blister |
Legal status | na lékařský předpis |
Active substance | ANASTROZOLE (ANASTROZOLUM) |
ATC group | L02BG03 |
ATC group name | ANASTROZOL |
Doping | Antagonisté a modulátory hormonů (nelze pro léčbu sportovců použít vůbec). Bližší informace viz http://www.antidoping.cz/. |
Marketing authorisation information
Registration Number | 44/1296/97-C |
---|---|
Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
Placed on the market till | 30. 09. 2021 |
MA Holder | AstraZeneca AB, Södertälje |
MA Holder country | ŠVÉDSKO |
Actual MA holder | Laboratoires Juvisé Pharmaceuticals, Villeurbanne |
Actual MA holder country | FRANCIE |